Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review

被引:0
作者
Mohammad Zubair
Jamal Ahmad
机构
[1] University of Tabuk,Department of Medical Microbiology, Faculty of Medicine
[2] Aligarh Muslim University,Rajiv Gandhi Centre for Diabetes and Endocrinology, Faculty of Medicine, J.N. Medical College
来源
Reviews in Endocrine and Metabolic Disorders | 2019年 / 20卷
关键词
Cytokines; Diabetic ulcers; Growth factors; Molecular process; Wound healing; Mechanism; Vascular endothelial growth factor; Insulin;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the review is to examine the role of growth factors and cytokines in the management of Diabetic Foot Ulcers, such as platelet derived growth factor (PDGF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF) and Insulin like growth factor (IGF). Taking this a step further, the role of Hypoxia-inducible factors (HIFs), Transforming growth factor beta 1 (TGF-β-1) and other growth factors have also been examined, with regard to the treatment of diabetic foot ulcers. The roles of these above-mentioned growth cytokines have been analyzed by studying various scholastic articles. The complete process of wound healing is implemented and regulated by numerous cytokines and human growth factors. The findings of the study indicate that wound healing of diabetic foot ulcers is a complex and extremely challenging biological and molecular process that involves coordinated efforts of multiple cell types. The therapeutic effects of various growth factors in the clinical management of wounds are chronic venous ulcers, pressure ulcers, and diabetic foot ulcers. It has been concluded that altercations of various cytokines are found in patients enduring diabetic foot ulcers. In a similar way, changes in the level of cytokines are also found in patients suffering from other diabetic complications such as diabetic nephropathy, retinopathy, and neuropathy. Subsequently, the diabetic wound healing process can be accelerated by regulating the levels of the cytokines.
引用
收藏
页码:207 / 217
页数:10
相关论文
共 196 条
  • [1] Cho NH(2007)Standards of medical care in diabetes Diabetes Care 30 S4-S41
  • [2] Shaw JE(2018)IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045 Diabetes Res Clin Pract 138 271-281
  • [3] Karuranga S(2001)Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 1343-1350
  • [4] Huang Y(2017)Advanced growth factor delivery systems in wound management and skin regeneration Molecules. 22 1259-S21
  • [5] da Rocha Fernandes JD(2014)Advanced glycation end products (AGE) and diabetes. Cause, effect, or both Curr Diab Rep 14 453-393
  • [6] Ohlrogge AW(2016)Human acellular dermal wound matrix for complex diabetic wounds J Wound Care 25 S17-578
  • [7] Malanda B(2015)Vascular endothelial growth factor: therapeutic possibilities and challenges for the treatment of ischemia Cytokine 71 385-571
  • [8] Tuomilehto J(2014)Clinical application of growth factors and cytokines in wound healing Wound Repair Regen 22 569-L879
  • [9] Lindström J(2015)Topical application of recombinant platelet-derived growth factor increases the rate of healing and the level of proteins that regulate this response Int Wound J 12 564-358
  • [10] Eriksson JG(2017)IL-22R ligands IL-20, IL-22, and IL-24 promote wound healing in diabetic db/db mice PLoS One 12 L868-238